SCHEMBL437084

SCHEMBL437084

COC(=O)c1cc(C)c(C)c(Br)c1CBr

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
NR4A2 P43354 2/20 0.35
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 4/20 0.34
GAA P10253 3/20 0.34
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA7 P43166 2/20 0.34
CA9 Q16790 2/20 0.34
CA14 Q9ULX7 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
PDK2 Q15119 1/20 0.34
PDK4 Q16654 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
PDGFRB P09619 1/20 0.34
FGFR1 P11362 1/20 0.34
PDGFRA P16234 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21932866 0.84 SOS1 (0.37) MAPTNR4A2KDM4EALDH1A1GAA
SCHEMBL31558276 0.77 KDM4E (0.46) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL31188992 0.75 XDH (0.44) MAPTNR4A2ALDH1A1GAACA12
SCHEMBL31188994 0.75 XDH (0.44) MAPTNR4A2ALDH1A1GAACA12
SCHEMBL438401 0.75 KDM4E (0.53) MAPTKDM4EALDH1A1GAACA12
SCHEMBL31267295 0.74 SOS1 (0.36) MAPTNR4A2ALDH1A1GAAHPGD
SCHEMBL31496988 0.74 SOS1 (0.45) MAPTNR4A2KDM4EALDH1A1GAA
SCHEMBL31496841 0.74 SOS1 (0.45) MAPTNR4A2KDM4EALDH1A1GAA
SCHEMBL438452 0.73 CA1 (0.40) MAPTNR4A2KDM4EALDH1A1GAA
SCHEMBL28447033 0.73 KDM4E (0.42) MAPTKDM4EALDH1A1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716326-B2 Isoindolinone derivatives, preparation method thereof and a pharmaceutical composition comprising same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2014-05-06 US disclosed
US-20120065396-A1 ISOINDOLINONE DERIVATIVES, PREPARATION METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION COMPRISING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065396-A1 ISOINDOLINONE DERIVATIVES, PREPARATION METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION COMPRISING SAME PPIP5K2, SOST, ALPL MAPT 148/4885NR4A2 2956/4885KDM4E 2116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.